Co-Diagnostics Inc
NASDAQ:CODX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Co-Diagnostics Inc
NASDAQ:CODX
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Co-Diagnostics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Co-Diagnostics Does
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 115 full-time employees. The company went IPO on 2017-07-12. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA).
- Headquarters
- United States of America US
- Employees
- 132
- IPO date
- Jul 12, 2017